3654 results for «372»
3654 results
Mitral and other valvular and structural interventions
15 Dec 2022 – From GulfPCR-GIM 2022
Take advantage of this GulfPCR-GIM 2022 session to observe inadvertent pulmonary artery puncture during balloon valvuloplasty in a pregnant patient with severe rheumatic mitral stenosis, device sizing in transcatheter closure of a ruptured sinus of Valsalva aneurysm, and more!
Left main and multivessel disease - Session 1
15 Dec 2022 – From GulfPCR-GIM 2022
Consult this session on left main and multivessel disease to discover a selection of cases presented during Gulf PCR 2022: multiple bifurcation lesions in an octogenarian and high-bleeding risk case, left anterior descending CTO complicated by left main thrombus with left main trifurcation stenting, and much more!
STEMI - Tools, devices and techniques
15 Dec 2022 – From GulfPCR-GIM 2022
Among the 4 GulfPCR-GIM 2022 cases presented in this session, discover a curious case of type 4 dual left anterior descending artery presenting with STEMI, or an inferior wall STEMI with complete heart block in anomalous right coronary artery.
STEMI - Adjunctive pharmacotherapy
15 Dec 2022 – From GulfPCR-GIM 2022
This GulfPCR-GIM 2022 session will enable you to view a case of cardiogenic shock on anterior STEMI, as well as a complicated double-vessel intervention in inferior wall myocardial infarction with cardiogenic shock and acute LVF-PCI-RCA and LMCA-LAD, among others!
Left main and multivessel disease - Session 2
15 Dec 2022 – From GulfPCR-GIM 2022
View a sudden LM stem occlusion, a LM dissection during CTO, or even a rotablation in LM triple vessel disease in severe left ventricle dysfunction, and much more in this GulfPCR-GIM 2022 session.
The why and how of performing plaque modification in calcified lesions
15 Dec 2022 – From GulfPCR-GIM 2022
Consult this session to learn more about the different kinds of lesions we face during coronary angiography and the different tools and techniques available to treat calcified lesions, as well as to discover how to prepare for each procedure to treat calcified lesion and how to manage complications.
Bifurcation lesion - Tools, devices and techniques
15 Dec 2022 – From GulfPCR-GIM 2022
This GulfPCR-GIM 2022 session will get you thinking about how to best plan for severe left main bifurcation and severe calcification/low ejection fraction in non-surgical candidates, and how to manage difficult decisions in left main bifurcation stenting, among others!
CTO - Tools, devices and techniques
15 Dec 2022 – From GulfPCR-GIM 2022
In this GulfPCR-GIM 2022 session, learn how a left anterior descending in-stent CTO was rescued by epicardial retrograde wiring, how a guidewire was redirected using a dual lumen microcath, how a CTO intervention was treated in an anomalous right coronary artery, and more!
Coronary sinus reducer for microvascular angina
28 Feb 2020
A 61-year-old man with a history of 2-vessel coronary artery stenting, hypertension and type-2 diabetes mellitus was admitted 5 times within September 2017 and November 2018 for recurrent angina CCS class III-IV refractory to therapy with nitrates, b-blockers and ranolazine in maximally tolerated doses...
Concomitant left atrial appendage occlusion and transcatheter aortic valve replacement among patients with atrial fibrillation – The WATCH-TAVR Trial
26 Oct 2023
Panos Xaplanteris provides his take on WATCH-TAVR results which were presented by Samir R. Kapadia at TCT Congress 2023.
Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - The WATCH TAVR Trial
Author
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
Five-year outcomes of the randomised trial of fractional flow reserve guided PCI compared to coronary artery bypass grafting: FAME 3
02 Apr 2025
Kalaivani Mahadevan provides her take on the five-year outcomes of the FAME 3 trial presented by William F. Fearon at ACC.25 in Chicago.
Author
The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis
22 Mar 2022
Daniele Giacoppo analyses the main results of the FLAVOUR trial which were presented by Bon-Kwon Koo, from Seoul National University Hospital, South Korea at the American College of Cardiology 2022.
Author
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR
29 Mar 2025
Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.
Author
Author
